ArticleExperimental and therapeutic medicine2019

Protective effect of rivaroxaban on arteriosclerosis obliterans in rats through modulation of the toll-like receptor 4/NF-κB signaling pathway.

Xinjiang Lou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.